/

Other

/

Apotex Inc.

Apotex Inc.

Apotex Inc.

Verified Nov 2026

Other

·

Canada flag

Toronto, Ontario

·

Since 1974

Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.

Apotex Inc.

Verified Nov 2026

AT A GLANCE

Founded

1974

Headquarters

Canada flag

Toronto, Ontario

Employees

5,000-10,000

Ownership

Apotex Inc. at a glance

Revenue

$1-5B

Est. band

Employees

5,000-10,000

Founded

1974

Headquarters

Toronto, Ontario

Import activity

2051

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Consumer Goods

Sourcing and import activity

From US customs bill-of-lading records

US sea imports

2051

Named foreign suppliers

50

Top origins

India · China · Oman · Sri Lanka

Chart of the supplier's US import shipment volume trend over time

Shared foreign counterparties do not establish that these companies buy from Apotex Inc..

What this tells a buyer

Apotex recorded 2,051 inbound shipments across documented customs entries, with volume sourced from India (Gland Pharma at 4,819 shipments) and China (Shandong Qilu Medicines at 1,032 shipments), along with materials from nine other countries.

The company manufactures approximately 25 billion doses annually and operates three divisions: Apotex Inc. for generics, Apobiologix for biosimilars, and Apotex Consumer Products for branded and natural health offerings, spanning over 1,000 products.

Founded by Dr. Barry Sherman, Apotex remains privately owned and ranks among pharmaceutical manufacturers by output and geographic reach.

Source: US customs bill-of-lading records and public filings · Last verified Nov 13, 2026

STABILITY SIGNALS

Established & active

52 years in operation (founded 1974).

2,051 US import shipments on record.

Overview

Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.

At a glance

Attribute

Detail

Founded

1974

Headquarters

Toronto, Ontario

Employees

5,000-10,000

Revenue

$1-5B (estimated)

What Apotex Inc. makes

The company manufactures approximately 25 billion doses annually and operates three divisions: Apotex Inc. for generics, Apobiologix for biosimilars, and Apotex Consumer Products for branded and natural health offerings, spanning over 1,000 products.

Products and capabilities described on the company's own site include Suspension (source: apotex.com).

Trade and customs footprint

Apotex recorded 2,051 inbound shipments across documented customs entries, with volume sourced from India (Gland Pharma at 4,819 shipments) and China (Shandong Qilu Medicines at 1,032 shipments), along with materials from nine other countries. US customs bill-of-lading records list 2051 inbound shipments across 50 foreign suppliers, with top origins including India · China · Oman · Sri Lanka.

Latest developments

Company details

Founded by Dr. Barry Sherman, Apotex remains privately owned and ranks among pharmaceutical manufacturers by output and geographic reach. Apotex Inc. was founded in 1974, has an estimated 5,000-10,000 employees, and is headquartered in Toronto, Ontario. On the LightSource stability read it is rated "Established & active": 52 years in operation (founded 1974). 2,051 US import shipments on record.

Frequently asked questions

What does Apotex Inc. do?

Apotex Inc. is a privately held Canadian pharmaceutical manufacturer headquartered in Toronto, Ontario, founded in 1974. The company employs 5,000–10,000 people and generates an estimated $1–5B in annual revenue. It manufactures generic drugs, biosimilars, active pharmaceutical ingredients, and consumer health products across more than 45 countries, serving cardiovascular, CNS, oncology, and other therapeutic areas. In 2026, Apotex completed a strategic transaction with Cumberland Pharmaceuticals and established a sterile filling partnership with Halo Pharmaceuticals.

Where is Apotex Inc. headquartered?

Apotex Inc. is headquartered in Toronto, Ontario (150 Signet Drive, Toronto, Ontario, M9L 1T9).

When was Apotex Inc. founded?

Apotex Inc. was founded in 1974.

How big is Apotex Inc.?

Apotex Inc. has an estimated 5,000-10,000 employees, with revenue in the $1-5B range (estimated).

Does Apotex Inc. import from overseas suppliers?

US customs bill-of-lading records show 2051 inbound shipments for Apotex Inc., with top origins including India · China · Oman · Sri Lanka.

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Toronto, Ontario (HQ)Headquarters · L 1T9, Canada
Toronto, Ontario (HQ)150 Signet Drive, Toronto, Ontario, M9L 1T9, CanadaHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.